Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Non-Hodgkin 14Leukemia, Myeloid, Acute 14Burkitt Lymphoma 14Lymphoma, Mantle-Cell 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Follicular 13Lymphoma, B-Cell, Marginal Zone 13Hodgkin Disease 13Lymphoma, Large-Cell, Immunoblastic 12Multiple Myeloma 11Leukemia, Myeloid, Chronic-Phase 11Blast Crisis 11Lymphoma, T-Cell, Cutaneous 10Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10Leukemia, Myeloid, Accelerated Phase 10Leukemia, Hairy Cell 10Leukemia 10Leukemia, Myelomonocytic, Chronic 9Congenital Abnormalities 9Sezary Syndrome 8Mycosis Fungoides 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 7Lymphoma 7Waldenstrom Macroglobulinemia 6Primary Myelofibrosis 6Neoplasms 6Lymphoma, Large-Cell, Anaplastic 6

Interventions

fludarabine phosphate 4fludarabine 3Whole-Body Irradiation 3Thiotepa 3Melphalan 3Cyclophosphamide 3Therapeutics 2Busulfan 2Antilymphocyte Serum 2Alemtuzumab 2thymoglobulin 1fosphenytoin 1Vaccination 1Photopheresis 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Injections 1Clofarabine 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Immunologic Deficiency Syndromes × Therapeutics × Other hematologic neoplasm × Clear all
NCT05655546 2025-08-08

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Scripps Translational Science Institute

Phase NA Terminated
2,117 enrolled 6 charts
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Graft vs Host Disease, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, HIV Infections

NCT01050439 2015-04-15

Unrelated Donor Transplant for Malignant and Non-Malignant Disorders

Columbia University

Phase 2 Terminated
22 enrolled
LymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡